Anavex Life Sciences Corp (AVXL)

[JB3729]

Companies evolve. AVXL became a totally different Company after Missling became CEO. He attracted quality board members and a world class SAB. Missling raised capital for clinical trials, which have demonstrated A2-73's excellent safety profile and remarkable efficacy sooner than anticipated.

To dwell on the pre-Missling era is a fool's game. Of course, hit piece writers play the fool's game. It's the best they can come up with to attack AVXL and prey on the gullible.